URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Wojciech Zareba

Concepts (600)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Electrocardiography
119
1994
782
15.280
Why?
Long QT Syndrome
88
1994
389
14.400
Why?
Defibrillators, Implantable
86
2000
421
13.550
Why?
Myocardial Infarction
82
1994
681
11.370
Why?
Heart Rate
63
1995
470
10.020
Why?
Death, Sudden, Cardiac
67
1994
295
8.060
Why?
Heart Failure
36
2004
389
7.990
Why?
Heart Conduction System
28
1994
153
7.390
Why?
Electrocardiography, Ambulatory
37
1990
93
7.010
Why?
Tachycardia, Ventricular
37
1994
157
6.960
Why?
Ventricular Dysfunction, Left
30
2001
169
6.760
Why?
Arrhythmias, Cardiac
29
1994
248
5.160
Why?
Risk Assessment
64
2001
878
4.730
Why?
Cardiac Resynchronization Therapy
15
2010
89
4.130
Why?
Humans
301
1986
36400
3.860
Why?
Male
227
1986
19713
3.690
Why?
Risk Factors
98
1994
2318
3.660
Why?
Female
218
1986
19826
3.470
Why?
Arrhythmogenic Right Ventricular Dysplasia
11
2003
20
3.440
Why?
Middle Aged
139
1986
9877
3.070
Why?
Ether-A-Go-Go Potassium Channels
13
2002
56
3.050
Why?
Mutation
31
1995
1229
3.030
Why?
Genetic Predisposition to Disease
26
1999
329
3.000
Why?
Diagnosis, Computer-Assisted
8
2005
66
2.960
Why?
Electric Countershock
15
2004
98
2.860
Why?
Ventricular Fibrillation
15
2003
97
2.810
Why?
Coronary Disease
18
1990
266
2.750
Why?
Aged
105
1986
7272
2.710
Why?
Coronary Artery Disease
11
2003
96
2.700
Why?
Survival Analysis
41
1997
598
2.600
Why?
Proportional Hazards Models
56
1998
453
2.490
Why?
Stroke Volume
26
2002
161
2.490
Why?
Myocardial Ischemia
15
1994
127
2.470
Why?
KCNQ1 Potassium Channel
15
2002
76
2.470
Why?
Treatment Outcome
52
2001
2623
2.370
Why?
Adrenergic beta-Antagonists
27
1998
175
2.300
Why?
Prognosis
45
1994
1080
2.280
Why?
Adult
108
1986
11345
2.190
Why?
Atrial Fibrillation
10
2003
115
2.110
Why?
Cardiac Pacing, Artificial
8
2005
163
2.110
Why?
Anti-Arrhythmia Agents
10
1994
82
2.100
Why?
Genotype
37
1995
487
2.030
Why?
Follow-Up Studies
54
1994
1857
2.030
Why?
Cardiology
5
1991
55
2.010
Why?
Heart Arrest
23
1994
153
1.820
Why?
Heart Diseases
8
1991
145
1.810
Why?
Sodium Channels
10
1998
124
1.810
Why?
Sotalol
6
2003
16
1.750
Why?
Tachycardia, Sinus
3
1997
7
1.740
Why?
Polymorphism, Genetic
9
2001
199
1.730
Why?
Pacemaker, Artificial
7
2004
164
1.580
Why?
Time Factors
36
1990
3201
1.560
Why?
Torsades de Pointes
8
1997
32
1.560
Why?
Syncope
22
1994
115
1.550
Why?
Romano-Ward Syndrome
7
2007
37
1.550
Why?
Coronary Artery Bypass
4
2003
115
1.510
Why?
Signal Processing, Computer-Assisted
13
1995
101
1.500
Why?
Algorithms
10
2003
537
1.490
Why?
Recurrence
28
1997
697
1.450
Why?
Ventricular Premature Complexes
7
2003
18
1.450
Why?
Multivariate Analysis
23
1995
531
1.430
Why?
Randomized Controlled Trials as Topic
7
2003
409
1.420
Why?
Periodicals as Topic
2
2011
79
1.410
Why?
Ventricular Function, Left
7
2005
98
1.360
Why?
Potassium Channels, Voltage-Gated
6
2002
37
1.340
Why?
Phenotype
27
1995
762
1.330
Why?
Cardiomyopathy, Dilated
7
1994
44
1.320
Why?
Echocardiography
14
2000
232
1.320
Why?
Survival Rate
25
2000
619
1.280
Why?
Predictive Value of Tests
19
1994
601
1.260
Why?
Cardiovascular Diseases
10
2001
276
1.210
Why?
Severity of Illness Index
21
2001
919
1.180
Why?
Potassium Channels
8
2002
130
1.160
Why?
Sex Factors
16
1995
584
1.160
Why?
Adolescent
45
1986
4752
1.140
Why?
Kaplan-Meier Estimate
21
2007
224
1.130
Why?
Sensitivity and Specificity
20
1998
905
1.130
Why?
Prospective Studies
31
1999
1677
1.120
Why?
Ventricular Function
4
1995
37
1.110
Why?
Multicenter Studies as Topic
8
2001
128
1.100
Why?
Retrospective Studies
23
1998
2260
1.060
Why?
Magnetic Resonance Imaging
4
2006
1010
1.060
Why?
Heart Ventricles
12
1990
214
1.060
Why?
Cardiac Resynchronization Therapy Devices
3
2011
13
1.040
Why?
Journal Impact Factor
2
2011
5
1.030
Why?
Bundle-Branch Block
6
2003
51
1.020
Why?
Aza Compounds
3
2008
24
1.010
Why?
Angiotensin-Converting Enzyme Inhibitors
4
2002
51
1.000
Why?
Quinolines
3
2008
46
0.980
Why?
Environmental Exposure
4
2004
197
0.980
Why?
Anti-Infective Agents
3
2008
74
0.960
Why?
Biological Markers
16
2000
564
0.950
Why?
Air Pollutants
6
2001
181
0.940
Why?
Mutation, Missense
5
2002
87
0.940
Why?
Heterozygote
10
1998
122
0.940
Why?
Cause of Death
10
2001
159
0.920
Why?
Telemedicine
3
2005
34
0.910
Why?
Registries
21
1998
223
0.900
Why?
Practice Guidelines as Topic
7
2007
304
0.890
Why?
Angina, Unstable
6
1994
35
0.870
Why?
Child
32
1994
4086
0.850
Why?
Societies, Medical
5
2001
139
0.840
Why?
European Continental Ancestry Group
5
2006
226
0.830
Why?
Glomerular Filtration Rate
2
2006
88
0.820
Why?
Carbon
4
2004
79
0.820
Why?
Diabetes Mellitus, Type 2
4
2001
225
0.810
Why?
Muscle Proteins
2
2008
150
0.800
Why?
Cholesterol Ester Transfer Proteins
2
2007
15
0.800
Why?
Research Design
5
2002
333
0.790
Why?
Heart Failure, Diastolic
1
2011
1
0.790
Why?
Cohort Studies
14
1994
969
0.770
Why?
Lipoproteins
4
2001
99
0.760
Why?
United States
22
1991
2630
0.760
Why?
C-Reactive Protein
10
2002
119
0.740
Why?
Exercise
5
2001
182
0.740
Why?
Young Adult
17
2008
1074
0.730
Why?
Chi-Square Distribution
16
1999
333
0.730
Why?
Sequence Deletion
2
2007
129
0.720
Why?
Reproducibility of Results
15
1998
884
0.720
Why?
Posture
1
2010
113
0.710
Why?
von Willebrand Factor
4
1999
68
0.710
Why?
African Continental Ancestry Group
3
2006
121
0.700
Why?
Child, Preschool
22
1995
2612
0.700
Why?
Hospitalization
7
2004
377
0.690
Why?
Air Pollution
4
2005
45
0.680
Why?
Terminology as Topic
2
2006
107
0.680
Why?
Lipids
10
1999
167
0.670
Why?
DNA
2
2011
856
0.670
Why?
Consensus Development Conferences as Topic
1
2008
7
0.670
Why?
Ventricular Dysfunction
1
2008
8
0.670
Why?
Cation Transport Proteins
3
2002
22
0.660
Why?
Incidence
13
2006
679
0.660
Why?
Kidney Diseases
2
2009
171
0.650
Why?
Angioplasty, Balloon, Coronary
2
2005
68
0.650
Why?
Hypertension
3
2003
300
0.640
Why?
Obesity
3
2000
335
0.630
Why?
Smoking
3
2000
390
0.630
Why?
Infant
17
1995
2249
0.610
Why?
Physicians
2
2005
159
0.600
Why?
Hyperglycemia
1
2008
90
0.590
Why?
Age Factors
12
1995
1121
0.590
Why?
Cardiomyopathies
5
2003
85
0.580
Why?
Angiotensinogen
1
2006
8
0.580
Why?
Risk
9
2004
358
0.570
Why?
Polymorphism, Single Nucleotide
5
2007
84
0.570
Why?
Regression Analysis
11
1994
524
0.570
Why?
Particulate Matter
5
2006
48
0.560
Why?
Probability
10
2001
294
0.560
Why?
Models, Biological
2
2011
1023
0.560
Why?
Comorbidity
9
1999
374
0.550
Why?
Mental Health
1
2007
85
0.550
Why?
Attitude of Health Personnel
2
2005
293
0.550
Why?
Angioplasty, Balloon
1
2006
72
0.540
Why?
Heart
7
1995
242
0.530
Why?
Diabetes Mellitus
2
2001
169
0.530
Why?
Sex Distribution
9
2003
154
0.530
Why?
Models, Economic
1
2005
27
0.530
Why?
Circadian Rhythm
2
2004
85
0.530
Why?
Cholesterol, HDL
5
2003
61
0.520
Why?
Trans-Activators
3
2002
364
0.520
Why?
Aged, 80 and over
14
2004
2513
0.520
Why?
Gonadal Steroid Hormones
1
2005
36
0.520
Why?
Public Opinion
1
2005
16
0.510
Why?
Health Care Costs
1
2005
112
0.490
Why?
Critical Illness
1
2005
53
0.490
Why?
Choice Behavior
1
2005
47
0.490
Why?
Tachycardia, Supraventricular
3
1990
20
0.480
Why?
Sequence Analysis, Protein
1
2003
13
0.480
Why?
Ion Channels
9
1995
154
0.470
Why?
Steroids
1
2004
54
0.470
Why?
Statistics, Nonparametric
11
2001
256
0.460
Why?
Reference Values
6
1999
441
0.460
Why?
Case-Control Studies
9
1997
618
0.460
Why?
DNA-Binding Proteins
3
2002
687
0.460
Why?
Pirenzepine
1
2003
4
0.450
Why?
Jervell-Lange Nielsen Syndrome
3
2002
11
0.450
Why?
Sequence Alignment
1
2003
193
0.440
Why?
Haloperidol
1
2003
38
0.440
Why?
Myocardial Contraction
3
2011
113
0.440
Why?
Myocardium
3
2006
325
0.430
Why?
Autonomic Nervous System
5
2001
70
0.430
Why?
Particle Size
9
2002
202
0.430
Why?
Ventricular Remodeling
3
2010
43
0.430
Why?
Logistic Models
11
2000
578
0.410
Why?
Drug Approval
1
2002
20
0.410
Why?
Age Distribution
8
2003
216
0.400
Why?
Electrophysiology
9
1994
247
0.390
Why?
Antipsychotic Agents
1
2003
116
0.390
Why?
Inflammation
6
2002
550
0.380
Why?
Disease Progression
7
2002
519
0.380
Why?
Patient Selection
4
2008
209
0.380
Why?
Blood Urea Nitrogen
4
2005
43
0.370
Why?
Analysis of Variance
6
1994
725
0.360
Why?
Spain
4
2008
18
0.350
Why?
Monitoring, Physiologic
2
2010
102
0.350
Why?
Mortality
3
1997
87
0.350
Why?
Metabolic Syndrome X
3
2003
58
0.350
Why?
Odds Ratio
8
1995
304
0.350
Why?
Cholesterol
3
1997
139
0.350
Why?
Ion Channel Gating
2
2011
128
0.340
Why?
Myocardial Revascularization
2
2006
23
0.340
Why?
Biopsy
2
2010
359
0.330
Why?
Recovery of Function
2
2009
111
0.330
Why?
Equipment Design
5
2006
247
0.320
Why?
Hospital Mortality
3
2006
141
0.320
Why?
Baroreflex
3
2004
22
0.320
Why?
Connexin 43
2
2006
42
0.320
Why?
Blood Pressure
4
2007
474
0.320
Why?
Up-Regulation
3
2006
372
0.320
Why?
Diphenhydramine
1
1997
9
0.320
Why?
Histamine H1 Antagonists
1
1997
16
0.310
Why?
DNA Mutational Analysis
5
2002
189
0.310
Why?
Clinical Trials as Topic
6
2002
675
0.300
Why?
Evidence-Based Medicine
2
2009
199
0.300
Why?
ROC Curve
5
1998
126
0.300
Why?
Death
2
2003
23
0.300
Why?
KCNQ Potassium Channels
4
2002
19
0.290
Why?
Equipment Failure
4
2008
74
0.290
Why?
Asthma
3
1999
294
0.290
Why?
Fibrin Fibrinogen Degradation Products
4
1999
50
0.280
Why?
New York
6
2001
1282
0.280
Why?
Women's Health
1
1997
61
0.280
Why?
Phospholipases A
2
2006
38
0.280
Why?
Angina Pectoris
4
1994
48
0.280
Why?
Body Mass Index
3
2000
211
0.280
Why?
Plasminogen Activator Inhibitor 1
3
1999
40
0.280
Why?
Inhalation Exposure
2
2007
87
0.270
Why?
Hemodynamics
2
2002
279
0.270
Why?
Pregnancy Complications, Cardiovascular
3
1998
37
0.260
Why?
Genetic Testing
5
2003
102
0.260
Why?
Databases, Factual
2
2005
151
0.260
Why?
Prevalence
3
2003
541
0.250
Why?
Infant, Newborn
8
2007
1831
0.250
Why?
Therapy, Computer-Assisted
2
2008
13
0.250
Why?
Coronary Vessels
2
2004
135
0.240
Why?
Canada
3
2007
76
0.240
Why?
Blood Glucose
3
2001
467
0.240
Why?
Flecainide
2
2001
12
0.230
Why?
Testosterone
2
2004
165
0.230
Why?
Confidence Intervals
3
2007
165
0.230
Why?
Convalescence
3
1994
19
0.230
Why?
Pedigree
3
2002
225
0.230
Why?
Enzyme-Linked Immunosorbent Assay
3
1999
466
0.230
Why?
Dose-Response Relationship, Drug
3
1997
1138
0.230
Why?
Patient Admission
2
2007
83
0.230
Why?
Ventricular Dysfunction, Right
2
2009
19
0.220
Why?
Thrombosis
4
1999
199
0.220
Why?
International Cooperation
2
1998
69
0.220
Why?
Age of Onset
3
2001
122
0.220
Why?
Japan
2
2007
31
0.220
Why?
Combined Modality Therapy
4
1986
486
0.220
Why?
Remote Sensing Technology
1
2012
2
0.210
Why?
Serum Amyloid A Protein
4
2002
23
0.210
Why?
Cross-Over Studies
2
2009
126
0.210
Why?
Ventricular Function, Right
3
2005
27
0.210
Why?
Thrombospondins
1
2011
13
0.210
Why?
Emotions
2
2001
89
0.210
Why?
Defibrillators
1
2011
6
0.200
Why?
Arteritis
1
2011
15
0.200
Why?
Israel
2
2007
39
0.200
Why?
Ventricular Outflow Obstruction
1
2011
11
0.200
Why?
Oxidants, Photochemical
1
2011
28
0.200
Why?
Survivors
2
2006
114
0.200
Why?
Coronary Care Units
1
2011
18
0.200
Why?
Genetic Variation
2
2008
148
0.200
Why?
Hemostasis
2
1999
62
0.200
Why?
Referral and Consultation
2
2010
198
0.200
Why?
Cardiotoxins
1
2011
3
0.200
Why?
Drug Therapy, Combination
2
2008
390
0.200
Why?
Guideline Adherence
2
2008
83
0.200
Why?
Neuromuscular Nondepolarizing Agents
1
2011
14
0.200
Why?
Menopause
1
2011
43
0.190
Why?
Tachycardia, Paroxysmal
1
2010
11
0.190
Why?
Enalapril
1
2010
7
0.190
Why?
Spironolactone
1
2010
12
0.190
Why?
Cooperative Behavior
1
2012
101
0.190
Why?
Ozone
1
2011
83
0.190
Why?
Heart Defects, Congenital
1
2011
104
0.190
Why?
Language
1
2011
26
0.190
Why?
Databases, Genetic
1
2010
26
0.190
Why?
Heart Function Tests
3
2001
33
0.190
Why?
Pattern Recognition, Automated
2
2005
26
0.190
Why?
Gene Frequency
2
2006
87
0.190
Why?
Drug Evaluation, Preclinical
1
2011
79
0.190
Why?
Diagnosis, Differential
3
2000
878
0.190
Why?
Electrodes, Implanted
1
2011
56
0.190
Why?
Cardiology Service, Hospital
1
2010
2
0.190
Why?
Societies, Nursing
1
2010
3
0.190
Why?
Primary Prevention
2
2007
58
0.180
Why?
Heavy Ions
1
2010
2
0.180
Why?
Guidelines as Topic
1
2011
88
0.180
Why?
Adrenergic beta-Agonists
2
1999
55
0.180
Why?
Reference Standards
1
2010
45
0.180
Why?
Hypertriglyceridemia
2
2006
24
0.180
Why?
Forecasting
3
1998
178
0.180
Why?
Hospital Units
1
2010
18
0.180
Why?
Blood Coagulation Factors
4
2000
54
0.180
Why?
Life Change Events
1
2010
106
0.180
Why?
Disease-Free Survival
3
2001
202
0.180
Why?
Magnetic Resonance Angiography
1
2010
36
0.180
Why?
Internet
2
2007
95
0.180
Why?
Acute Coronary Syndrome
1
2009
10
0.180
Why?
Physician's Practice Patterns
2
2008
253
0.180
Why?
Radiation Dosage
1
2010
126
0.170
Why?
Germany
4
2005
26
0.170
Why?
Happiness
1
2009
12
0.170
Why?
Critical Care
1
2010
69
0.170
Why?
Silicones
1
2009
27
0.170
Why?
Statistics as Topic
3
2001
187
0.170
Why?
Hemostasis, Surgical
1
2008
11
0.170
Why?
Apolipoprotein A-I
1
2008
21
0.170
Why?
Lipase
1
2008
16
0.170
Why?
Lipoprotein(a)
1
2008
15
0.170
Why?
Tachycardia
2
1986
69
0.170
Why?
Punctures
1
2008
25
0.170
Why?
Coagulants
1
2008
13
0.170
Why?
Acetanilides
1
2008
9
0.160
Why?
Conserved Sequence
1
2009
103
0.160
Why?
Coronary Angiography
3
1998
91
0.160
Why?
Double-Blind Method
2
2005
998
0.160
Why?
Hypercholesterolemia
2
2005
49
0.160
Why?
Vagus Nerve
1
2008
40
0.160
Why?
Asian Continental Ancestry Group
1
2008
30
0.160
Why?
Chromatography, High Pressure Liquid
3
2002
210
0.160
Why?
Diagnostic Errors
1
2009
89
0.160
Why?
Femoral Artery
1
2008
82
0.160
Why?
Siblings
1
2008
33
0.160
Why?
Delayed Rectifier Potassium Channels
1
2008
10
0.160
Why?
Atrial Flutter
1
2008
25
0.160
Why?
Triglycerides
2
2003
105
0.160
Why?
Coronary Stenosis
2
2004
7
0.160
Why?
Fractals
3
2001
7
0.160
Why?
Cost-Benefit Analysis
2
2005
209
0.160
Why?
Catheter Ablation
1
2009
76
0.160
Why?
Discriminant Analysis
1
2007
22
0.150
Why?
Piperazines
1
2008
76
0.150
Why?
Medical History Taking
1
2008
67
0.150
Why?
African Americans
1
2010
214
0.150
Why?
Postoperative Complications
2
2001
743
0.150
Why?
Aryldialkylphosphatase
1
2007
6
0.150
Why?
Quality of Life
2
2007
509
0.150
Why?
Sodium
1
2008
302
0.150
Why?
Europe
3
2011
79
0.150
Why?
Natriuretic Peptide, Brain
1
2007
11
0.150
Why?
Platelet Glycoprotein GPIb-IX Complex
1
2007
5
0.150
Why?
Pregnancy, High-Risk
1
2007
14
0.150
Why?
Cardiac Output, Low
1
2007
16
0.150
Why?
International Normalized Ratio
1
2006
8
0.150
Why?
E-Selectin
1
2006
18
0.150
Why?
Patient Education as Topic
2
2005
219
0.150
Why?
Vehicle Emissions
1
2007
23
0.150
Why?
Hypolipidemic Agents
2
2002
26
0.150
Why?
Kidney
1
2010
582
0.150
Why?
Hemorrhage
1
2008
181
0.150
Why?
Radiotherapy, High-Energy
1
2006
24
0.140
Why?
NADPH Oxidase
1
2007
32
0.140
Why?
Diabetic Angiopathies
1
2007
35
0.140
Why?
Aging
2
1998
706
0.140
Why?
User-Computer Interface
1
2007
43
0.140
Why?
Threonine
1
2006
31
0.140
Why?
Point Mutation
2
2003
175
0.140
Why?
Methionine
1
2006
52
0.140
Why?
Nitric Oxide Synthase Type III
1
2007
75
0.140
Why?
Education, Medical, Continuing
1
2007
65
0.140
Why?
Homozygote
1
2006
90
0.140
Why?
Protein Precursors
1
2007
85
0.140
Why?
Health Knowledge, Attitudes, Practice
1
2010
279
0.140
Why?
Rest
1
2006
22
0.140
Why?
Surgical Procedures, Elective
1
2006
32
0.140
Why?
Health Personnel
1
2006
59
0.140
Why?
Outcome Assessment (Health Care)
2
2005
293
0.140
Why?
Electrophysiologic Techniques, Cardiac
1
2005
26
0.140
Why?
Arousal
2
2000
57
0.140
Why?
Paper
1
2005
8
0.140
Why?
Pregnancy Outcome
1
2007
136
0.130
Why?
Apolipoproteins B
2
2000
153
0.130
Why?
Information Storage and Retrieval
1
2005
29
0.130
Why?
Poland
1
2005
12
0.130
Why?
Dehydroepiandrosterone Sulfate
1
2005
7
0.130
Why?
Epidemiologic Studies
1
2005
21
0.130
Why?
Stress, Psychological
1
2009
283
0.130
Why?
Intercellular Adhesion Molecule-1
1
2006
127
0.130
Why?
Follicle Stimulating Hormone
1
2005
50
0.130
Why?
Zinc Oxide
1
2005
7
0.130
Why?
Medical Records Systems, Computerized
1
2005
35
0.130
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2006
48
0.130
Why?
Diabetes Complications
1
2005
66
0.130
Why?
Heart Rupture, Post-Infarction
1
2004
1
0.130
Why?
Insulin
3
1999
670
0.130
Why?
Prostheses and Implants
1
2005
87
0.130
Why?
Contrast Media
1
2007
268
0.130
Why?
Peptide Fragments
1
2007
301
0.130
Why?
Molecular Sequence Data
3
2002
2028
0.130
Why?
Software
1
2005
125
0.120
Why?
Amino Acid Sequence
2
2003
1231
0.120
Why?
Postoperative Period
1
2004
85
0.120
Why?
Sympathectomy
1
2004
21
0.120
Why?
Intermittent Claudication
1
2004
10
0.120
Why?
Heterozygote Detection
2
1999
28
0.120
Why?
Genes, Recessive
1
2003
38
0.120
Why?
Primary Health Care
1
2008
492
0.110
Why?
Endpoint Determination
1
2003
31
0.110
Why?
Thioridazine
1
2003
1
0.110
Why?
Risk Sharing, Financial
1
2003
4
0.110
Why?
Estradiol
1
2004
199
0.110
Why?
Hyperlipidemias
1
2003
46
0.110
Why?
Drug Labeling
1
2003
12
0.110
Why?
Benzodiazepines
1
2003
26
0.110
Why?
Dopamine Antagonists
1
2003
22
0.110
Why?
Apolipoproteins
4
2000
41
0.110
Why?
Atropine
1
2002
34
0.110
Why?
Lipoproteins, HDL
2
1997
32
0.110
Why?
Androgens
1
2004
139
0.110
Why?
History, 20th Century
2
1991
243
0.110
Why?
Exercise Test
3
1994
105
0.100
Why?
United States Food and Drug Administration
1
2002
42
0.100
Why?
Oxidoreductases Acting on CH-NH Group Donors
1
2001
3
0.100
Why?
Hyperhomocysteinemia
1
2001
3
0.100
Why?
Leukocyte Count
1
2001
159
0.100
Why?
Blood Proteins
1
2001
97
0.100
Why?
Gene Expression Profiling
1
2003
299
0.100
Why?
Sex Characteristics
2
1998
142
0.100
Why?
World Health
2
2011
62
0.100
Why?
Cardiolipins
1
2000
7
0.100
Why?
Endothelium, Vascular
2
2001
445
0.090
Why?
Models, Molecular
3
2002
366
0.090
Why?
Diabetes Mellitus, Type 1
1
2001
164
0.090
Why?
Longitudinal Studies
2
1997
390
0.090
Why?
Electroencephalography
1
2000
177
0.090
Why?
Autoantibodies
1
2000
105
0.090
Why?
Latex Fixation Tests
1
1999
19
0.090
Why?
Swimming
1
1999
9
0.090
Why?
Questionnaires
1
2005
998
0.090
Why?
Polymorphism, Single-Stranded Conformational
3
2002
41
0.080
Why?
Amino Acid Substitution
2
2007
132
0.080
Why?
Acoustic Stimulation
1
1999
173
0.080
Why?
Creatinine
2
2007
132
0.080
Why?
1-Alkyl-2-acetylglycerophosphocholine Esterase
2
2006
16
0.080
Why?
Codon, Nonsense
2
2007
55
0.080
Why?
Physicians, Family
2
2008
113
0.080
Why?
Models, Animal
2
2006
138
0.080
Why?
Systole
2
2005
40
0.080
Why?
Lipoproteins, LDL
1
1997
33
0.080
Why?
Membrane Potentials
2
2007
343
0.070
Why?
Phospholipases A2
2
2006
28
0.070
Why?
Sleep
2
2001
58
0.070
Why?
Family Health
3
1998
90
0.070
Why?
Rabbits
2
2006
704
0.070
Why?
Amiodarone
2
2002
10
0.070
Why?
Action Potentials
2
1990
256
0.070
Why?
Cerebrovascular Disorders
1
1997
110
0.070
Why?
Chromosomes, Human, Pair 7
1
1995
21
0.070
Why?
Chromosomes, Human, Pair 3
1
1995
16
0.070
Why?
Chromosomes, Human, Pair 11
1
1995
30
0.070
Why?
Life Tables
2
2004
39
0.070
Why?
Family
2
2001
201
0.070
Why?
Administration, Inhalation
2
2005
176
0.070
Why?
Genetic Markers
2
2003
132
0.070
Why?
Pregnancy
3
1998
1962
0.070
Why?
Suicide, Attempted
1
1997
209
0.060
Why?
Sputum
2
2004
57
0.060
Why?
Nitric Oxide
2
2004
252
0.060
Why?
Metoprolol
2
2000
10
0.060
Why?
Atenolol
2
2000
13
0.060
Why?
Blood Coagulation
2
2000
75
0.050
Why?
Sequence Analysis, DNA
2
2002
164
0.050
Why?
Nonlinear Dynamics
2
2001
34
0.050
Why?
Precipitating Factors
1
2011
5
0.050
Why?
Genetic Association Studies
1
2011
19
0.050
Why?
Genome-Wide Association Study
1
2011
23
0.050
Why?
Glucose Intolerance
1
2011
24
0.050
Why?
Glucose Tolerance Test
1
2011
69
0.050
Why?
Animals
4
2006
16270
0.050
Why?
Estrogen Replacement Therapy
1
2011
22
0.050
Why?
Environmental Monitoring
1
2011
65
0.050
Why?
Echocardiography, Doppler
1
2011
54
0.050
Why?
Computers, Handheld
1
2010
10
0.050
Why?
RNA, Messenger
2
2006
1857
0.050
Why?
Minnesota
1
2010
27
0.050
Why?
Atmosphere
1
2010
1
0.050
Why?
National Institutes of Health (U.S.)
2
2001
63
0.050
Why?
Climate
1
2010
4
0.050
Why?
Polymerase Chain Reaction
2
2003
594
0.050
Why?
Blood Volume
1
2010
52
0.050
Why?
Endocardium
1
2010
9
0.050
Why?
Desmosomes
1
2010
4
0.050
Why?
Oocytes
1
2011
133
0.050
Why?
Xenopus laevis
1
2011
164
0.040
Why?
Temperature
1
2010
253
0.040
Why?
Models, Statistical
1
2011
219
0.040
Why?
Protein Structure, Secondary
1
2009
91
0.040
Why?
Obesity, Morbid
1
2010
50
0.040
Why?
Dose-Response Relationship, Radiation
1
2010
218
0.040
Why?
Causality
1
2009
43
0.040
Why?
Early Ambulation
1
2008
5
0.040
Why?
Angiography
1
2009
93
0.040
Why?
Computer Simulation
1
2011
298
0.040
Why?
Fibrinogen
2
1999
152
0.040
Why?
Continental Population Groups
1
2010
117
0.040
Why?
Health Care Surveys
1
2010
159
0.040
Why?
Administration, Topical
1
2008
89
0.040
Why?
Decision Support Systems, Clinical
1
2008
22
0.040
Why?
Pressure
1
2008
135
0.040
Why?
Computational Biology
1
2009
67
0.040
Why?
Interviews as Topic
1
2009
181
0.040
Why?
Minority Groups
1
2008
56
0.040
Why?
Oscillometry
1
2008
24
0.040
Why?
Chromosome Mapping
2
1995
229
0.040
Why?
Genetic Linkage
2
1995
151
0.040
Why?
Frameshift Mutation
1
2007
23
0.040
Why?
Patient Satisfaction
1
2009
230
0.040
Why?
RNA Splice Sites
1
2007
17
0.040
Why?
Netherlands
1
2007
29
0.040
Why?
Mutagenesis, Insertional
1
2007
53
0.040
Why?
Ion Transport
1
2007
70
0.040
Why?
Postpartum Period
1
2007
38
0.040
Why?
Rats, Inbred SHR
1
2007
45
0.040
Why?
Sulfur Dioxide
1
2006
11
0.040
Why?
Injections, Intraperitoneal
1
2007
84
0.040
Why?
Glutamine
1
2007
63
0.040
Why?
Parity
1
2007
49
0.040
Why?
Aspartic Acid
1
2007
48
0.040
Why?
Aerosols
1
2007
113
0.040
Why?
Patient Readmission
1
2007
42
0.040
Why?
Telemetry
1
2007
27
0.040
Why?
Carbon Monoxide
1
2006
55
0.040
Why?
Internationality
1
2006
27
0.040
Why?
Automobile Driving
1
2007
33
0.040
Why?
Nitrous Oxide
1
2006
42
0.040
Why?
Arginine
1
2007
119
0.040
Why?
Glutamic Acid
1
2007
102
0.040
Why?
Protein Transport
1
2007
173
0.030
Why?
Enzyme Inhibitors
1
2008
438
0.030
Why?
Models, Cardiovascular
1
2006
70
0.030
Why?
Nebraska
1
2005
6
0.030
Why?
Gap Junctions
1
2006
68
0.030
Why?
Potassium
1
2007
306
0.030
Why?
Database Management Systems
1
2005
12
0.030
Why?
Propanolamines
1
2005
11
0.030
Why?
Gestational Age
1
2007
341
0.030
Why?
Placebo Effect
1
2005
34
0.030
Why?
Carbazoles
1
2005
28
0.030
Why?
Artificial Intelligence
1
2005
23
0.030
Why?
Length of Stay
1
2007
280
0.030
Why?
Lipopolysaccharides
1
2007
209
0.030
Why?
Equipment Failure Analysis
1
2005
73
0.030
Why?
Massachusetts
1
2005
32
0.030
Why?
Protein Structure, Tertiary
1
2007
379
0.030
Why?
Advisory Committees
1
2005
21
0.030
Why?
Smoking Cessation
1
2006
81
0.030
Why?
Radiotherapy
1
2006
198
0.030
Why?
Lymphocyte Subsets
1
2004
29
0.030
Why?
Respiratory System
1
2005
46
0.030
Why?
Heart Atria
1
2005
71
0.030
Why?
Cardiovascular System
1
2004
47
0.030
Why?
Ganglionectomy
1
2004
7
0.030
Why?
Blotting, Western
1
2006
668
0.030
Why?
Respiration
1
2004
181
0.030
Why?
Blood Chemical Analysis
1
2003
40
0.030
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2006
543
0.030
Why?
Factor Analysis, Statistical
1
2003
57
0.030
Why?
Rare Diseases
1
2003
28
0.030
Why?
Diseases in Twins
1
2003
37
0.030
Why?
Clinical Protocols
1
2003
105
0.030
Why?
Nucleic Acid Denaturation
1
2003
48
0.030
Why?
Oxidative Stress
1
2007
352
0.030
Why?
Entropy
1
2002
9
0.030
Why?
Immunohistochemistry
1
2006
1063
0.030
Why?
Exons
1
2003
163
0.030
Why?
Introns
1
2003
110
0.030
Why?
Hearing Loss, Sensorineural
1
2002
20
0.030
Why?
Principal Component Analysis
1
2001
31
0.030
Why?
Methylenetetrahydrofolate Reductase (NADPH2)
1
2001
5
0.030
Why?
Mexiletine
1
2001
13
0.020
Why?
Drug Monitoring
1
2001
36
0.020
Why?
beta 2-Glycoprotein I
1
2000
4
0.020
Why?
Cytokines
1
2004
572
0.020
Why?
Mitral Valve Insufficiency
1
2000
24
0.020
Why?
Immunoglobulin M
1
2000
140
0.020
Why?
Nadolol
1
2000
5
0.020
Why?
Administration, Oral
1
2001
309
0.020
Why?
Propranolol
1
2000
83
0.020
Why?
Bias (Epidemiology)
1
2000
44
0.020
Why?
Automation
1
1999
30
0.020
Why?
Factor VII
1
1999
9
0.020
Why?
Pilot Projects
1
2001
441
0.020
Why?
Binding Sites
1
2002
742
0.020
Why?
Factor VIIa
1
1999
22
0.020
Why?
Evaluation Studies as Topic
1
1999
243
0.020
Why?
Chronic Disease
1
2001
530
0.020
Why?
Glycoproteins
1
2000
206
0.020
Why?
Stress, Physiological
1
2000
109
0.020
Why?
Rats
1
2007
4386
0.020
Why?
Acute Disease
1
2000
580
0.020
Why?
Immunoglobulin G
1
2000
482
0.020
Why?
Abortion, Induced
1
1998
47
0.020
Why?
Base Sequence
1
2002
1704
0.020
Why?
Thallium Radioisotopes
1
1997
14
0.020
Why?
Gene Expression
1
2000
756
0.020
Why?
Arrhythmia, Sinus
1
1995
7
0.020
Why?

Visualizations


Zareba's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department